Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wesley A. Kidder"'
Autor:
Jordyn Silverstein, Katherine Van Loon, Samantha Maisel, Thomas A. Hope, Jessica Van Ziffle, Dianna Ng, Susan J. Fisher, Chloe E. Atreya, Wesley Allen Kidder
Publikováno v:
Endocrine Connections
Endocrine Connections, vol 8, iss 8
Endocrine Connections, Vol 8, Iss 8, Pp 1149-1158 (2019)
Endocrine Connections, vol 8, iss 8
Endocrine Connections, Vol 8, Iss 8, Pp 1149-1158 (2019)
Background Colorectal carcinoma (CRC) during the peri-partum period is challenging to diagnose due to the overlapping symptoms of CRC and pregnancy. This is the first case series to investigate clinicopathologic, hormonal and molecular features of CR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620d64fdff918d40f089f1b7ab5e3de7
http://europepmc.org/articles/PMC6686950
http://europepmc.org/articles/PMC6686950
Autor:
Andrea Grace Bocobo, Renee Wang, Spencer Behr, Julia C. Carnevale, Pelin Cinar, Eric Andrew Collisson, Lawrence Fong, Bridget P Keenan, Wesley Allen Kidder, Andrew H. Ko, Kanti Pallav Kolli, Megan Kennedy, Angela Laffan, Sorbarikor Piawah, Marin Pollak, Gabriel Schwartz, Julia Whitman, Li Zhang, Katherine Van Loon, Chloe Evelyn Atreya
Publikováno v:
Journal of Clinical Oncology. 40:3565-3565
3565 Background: MSS mCRC rarely responds to pembrolizumab monotherapy, but capecitabine and bevacizumab may induce immune-stimulatory effects. This study evaluates the safety, tolerability and preliminary efficacy of pembrolizumab in combination wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b0cb7553bec6240e5c442e36d6a2bbe
https://doi.org/10.1200/jco.2022.40.16_suppl.3565
https://doi.org/10.1200/jco.2022.40.16_suppl.3565
Autor:
Pelin Cinar, Li Zhang, Eric A. Collisson, Lawrence Fong, Chloe E. Atreya, Renee Wang, Andrea Grace Bocobo, Sneha Nalla, Wesley Allen Kidder, Gabriel L. Schwartz, Sheila Lindsay, Megan Kennedy, Julia Whitman, Julia Carnevale, Angela Laffan, Katherine Van Loon, Kanti Pallav Kolli, Spencer C. Behr, Patricia Zendejas, Andrew H. Ko
Publikováno v:
Journal of Clinical Oncology. 39:77-77
77 Background: MSS mCRC rarely responds to pembrolizumab monotherapy, but capecitabine and bevacizumab may induce immune-stimulatory effects. This study evaluates the safety, tolerability and preliminary efficacy of pembrolizumab in combination with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f1da8c6e147879bf5d6c994fbe8fc70
https://doi.org/10.1200/jco.2021.39.3_suppl.77
https://doi.org/10.1200/jco.2021.39.3_suppl.77
Autor:
Barbara L. Sommers, Wesley A. Kidder, David R. Minor, Philip J. DiSaia, Robert A. Nagourney, Cheryl A. Brewer, Steven S. Evans, Stephen E. Radecki
Publikováno v:
Gynecologic Oncology. 88:35-39
Objectives. The aim was to determine the safety and efficacy of gemcitabine plus cisplatin for patients with relapsed ovarian carcinoma and to compare ex vivo drug sensitivity profiles with clinical outcomes. Patients and methods. Previously treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::947ea561de28e8bf31d9dce97169cd79
https://doi.org/10.1006/gyno.2002.6855
https://doi.org/10.1006/gyno.2002.6855